Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ETON
ETON PHARMACEUTICALS, INC.
NASDAQ
$59.78
▼ DOWN 4.61% (-2.89)

KEY STATISTICS

Market Cap$1.64 B
52w High$66.37
52w Low$14.27
Dividend Yield—
Frequency—
P/E129.96
Volume588.69K
Shares Out.27.39M

COMPANY

LEADERSHIP

Sean E. Brynjelsen
CHIEF EXECUTIVE
Sean E. Brynjelsen

COMPENSATION 2026

Salary$712,433
Stock Awards$936,052
Incentive Plan Pay$354,792
All Other Comp.$17,500
Total$2,914,489

ABOUT

SECTOR
Healthcare
WENT PUBLIC
November 14, 2018
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
44

PRICE TARGET

Target High$70.00
Target Low$62.00
Target Median$68.00
Target Consensus$66.67

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$41.98M
NOV
5
THU

PRICE

$59.78 ▼ DOWN 4.61% (−$2.89)
$59.00$60.00$61.009:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM59.78

About Eton Pharmaceuticals, Inc.

https://www.etonpharma.com ↗

Eton Pharmaceuticals, Inc. develops and commercializes specialty drugs for rare diseases, including treatments for hypotension, hyperammonemia, adrenal insufficiency, seizures, and allergic conjunctivitis.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A PRODUCT ETON PHARMACEUTICALS, INC. IS KNOWN FOR

Alkindi Sprinkle
Alkindi Sprinkle

Alkindi Sprinkle is the first FDA-approved hydrocortisone oral granule formulation for precise dosing in pediatric patients with adrenocortical insufficiency from birth to under 17 years.

COMPETITORS

COMPETITOR
CORT COMPARE
CRNX COMPARE
NBIX COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Product— — — $37.59M
Product Sales and Royalties$22.46M $21.28M ▼$24.27M ▲—
License— $0 — —

ETFS HOLDING THIS STOCK

ETFS HOLDING
95
LISTED HERE
25
RANKED BY POSITION SIZE
VTS.AX
0.00% · 697.0K
XSU.TO
0.05% · 684.9K
XPH
2.10% · 197.0K
PSC
0.14% · 60.3K
FFTY
3.38% · 42.2K
GSSC
0.21% · 37.3K
AVSC
0.07% · 36.8K
DFMC
0.02% · 26.1K
XRS2.F
0.05% · 24.4K
AFSM
1.05% · 21.8K
OMFS
0.39% · 17.6K
RSSL
0.05% · 12.7K
EH
EHLS
1.13% · 10.6K
PILL
1.41% · 5.5K
SSCP
3.22% · 5.2K
RTWO.L
0.13% · 4.5K
SYZ
0.36% · 3.9K
HELX
0.49% · 2.6K
ACSG
0.23% · 1.9K
AI
AIMS
0.12% · 1.7K
URTY
0.02% · 1.1K
LITL
0.85% · 967
QSML
0.18% · 350
AESG
0.30% · 96
EB
EBI
0.00% · 4

INSTITUTIONAL OWNERSHIP

SHARES OWNED
49.22%
HOLDERS
183
TOP 12 OF 183 · RANKED BY POSITION SIZE
Opaleye Management Inc.
2.9M sh · $103.53M
Ecor1 Capital, LLC
2.2M sh · $78.62M
Blackrock, Inc.
1.9M sh · $68.63M
Vanguard Group Inc
1.3M sh · $22.81M
Nantahala Capital Management, LLC
1.2M sh · $42.57M
Morgan Stanley
768.0K sh · $27.8M
State Street Corp
701.8K sh · $25.4M
Geode Capital Management, LLC
652.3K sh · $23.62M
Oberweis Asset Management Inc/
501.6K sh · $18.16M
Royal Bank Of Canada
479.2K sh · $10.41M
Westside Investment Management, Inc.
472.5K sh · $10.27M
Cannell Capital LLC
455.4K sh · $9.9M

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity5
Return On Assets5
Debt To Equity2
Price To Earnings1
Price To Book1
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Thomas Suozzi
Thomas Suozzi
Purchase
2022-10-11

INSIDER TRADES

★
DIRECTOR
MAIER PAUL V
Purchase · 50.0K shares
2026-08-28
★
DIRECTOR
MAIER PAUL V
Sale · 36.4K shares
2026-08-28
★
DIRECTOR
MAIER PAUL V
Sale · 13.5K shares
2026-08-28
★
DIRECTOR
MAIER PAUL V
Sale · 128 shares
2026-08-28

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 4
4 GRADES IN THE LAST 12 MONTHS
B. Riley Securities BUY Canaccord Genuity BUY HC Wainwright & Co. BUY Craig-Hallum BUY

SECTORS PEERS

PEERPRICE
OMER$18.61COMPARE
LXRX$2.29COMPARE
MNPR$111.89COMPARE
OCGN$1.32COMPARE
FULC$3.85COMPARE
BCYC$4.20COMPARE
NMRA$1.39COMPARE
ADCT$1.14COMPARE